We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

38 hedge funds and large institutions have $36.2M invested in Annovis Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

1.93% less ownership

Funds ownership: 16.01% → 14.08% (-1.9%)

33% less funds holding

Funds holding: 57 → 38 (-19)

67% less capital invested

Capital invested by funds: $109M → $36.2M (-$72.7M)

68% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 28

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
38
Holders Change
-19
Holders Change %
-33.33%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
14
Reduced
10
Closed
28
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$5.61M
2
Millennium Management
Millennium Management
New York
+$3.57M
3
WFAG
Wescott Financial Advisory Group
Pennsylvania
+$2.39M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.14M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$8.86M
2
EI
EAM Investors
California
-$4.16M
3
ACM
AIGH Capital Management
Maryland
-$3.45M
4
EGI
EAM Global Investors
California
-$2.53M
5
Goldman Sachs
Goldman Sachs
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$7.29M +$1.78K +31 +0%
Voloridge Investment Management
2
Voloridge Investment Management
Florida
$3.45M +$364K +6,337 +6%
BlackRock
3
BlackRock
New York
$3.28M +$134K +2,333 +2%
Two Sigma Investments
4
Two Sigma Investments
New York
$3.1M +$5.61M +97,566 New
ACM
5
AIGH Capital Management
Maryland
$2.11M -$3.45M -60,000 -47%
Millennium Management
6
Millennium Management
New York
$2.08M +$3.57M +62,032 +1,729%
WFAG
7
Wescott Financial Advisory Group
Pennsylvania
$1.32M +$2.39M +41,607 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$1.3M +$137K +2,376 +6%
Morgan Stanley
9
Morgan Stanley
New York
$1.21M +$454K +7,896 +26%
Citadel Advisors
10
Citadel Advisors
Florida
$1.18M +$2.14M +37,222 New
MWM
11
Modera Wealth Management
New Jersey
$1.06M -$83.3K -1,448 -4%
Two Sigma Advisers
12
Two Sigma Advisers
New York
$959K +$1.56M +27,200 +907%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$826K +$222K +3,868 +17%
BCM
14
Bridgeway Capital Management
Texas
$749K – – –
WVP
15
Worth Venture Partners
New Jersey
$631K -$802K -13,956 -41%
Bank of America
16
Bank of America
North Carolina
$555K +$1M +17,478 New
State Street
17
State Street
Massachusetts
$521K -$51.7K -900 -5%
CC
18
Cannell & Co
New York
$514K +$11.5K +200 +1%
SIAP
19
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$460K -$351K -6,100 -30%
KCM
20
Knoll Capital Management
Florida
$451K -$1.44M -25,000 -64%
EL
21
Essex LLC
Illinois
$380K +$688K +11,962 New
VF
22
Virtu Financial
New York
$367K -$339K -5,895 -34%
Osaic Holdings
23
Osaic Holdings
Arizona
$349K +$532K +9,260 +532%
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$318K +$546K +9,500 New
Wells Fargo
25
Wells Fargo
California
$310K +$531K +9,240 +1,721%
1
2 3

ANVS Hedge Fund Activity: Q3 2021 in Review

38 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q3 2021, worth a combined $36.2M — down 67% from $109M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ANVS and 9 opened new positions — a net loss of 19 holders — while 10 trimmed existing stakes and 14 added.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $5.61M. The largest seller was Ikarian Capital, exiting entirely with an estimated $8.86M sold.

  • 38 institutional investors held Annovis Bio (ANVS) as of Q3 2021, down from 57 in Q2 2021.
  • Funds reported $36.2M of Annovis Bio stock for Q3 2021, down 67% quarter-over-quarter.
  • 9 funds opened new Annovis Bio positions in Q3 2021 and 28 closed out, a net change of -19 holders.
  • The largest Annovis Bio buyer in Q3 2021 was Two Sigma Investments, an estimated $5.61M added.
  • The largest Annovis Bio seller in Q3 2021 was Ikarian Capital, an estimated $8.86M sold.

Based on aggregated 13F filings for Q3 2021.